Iovance Biotherapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

Go back to Iovance Biotherapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
(NASDAQ: IOVA) Delayed: 4.08 +0.12 (3.03%)
Previous Close $3.96    52 Week High
Open $3.95    52 Week Low
Day High $4.23    P/E N/A 
Day Low $3.95    EPS
Volume 10,969,784